Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
ARYA Sciences Acquisition Corp IV incurred convertible notes of $1,000,000 with ARYA Sciences Holdings IV at no interest maturing on the effective date of an initial merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination.
- Instrument
- convertible notes
- Principal
- $1,000,000
- Counterparty
- ARYA Sciences Holdings IV
- Rate
- no interest
- Maturity
- on the effective date of an initial merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination
- Event
- incurrence
Exact text from the filing
On February 8, 2024, ARYA Sciences Acquisition Corp IV (the “Company”) issued an unsecured convertible promissory note (the “Fourth Promissory Note”) to ARYA Sciences Holdings IV (the “Sponsor”), pursuant to which the Company may borrow $1,000,000 (the “Working Capital Loan”) from the Sponsor for general corporate purposes
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
ARYA Sciences Acquisition Corp IV entered into Fourth Promissory Note with ARYA Sciences Holdings IV (the Sponsor) valued at $1,000,000 (effective 2024-02-08).
- Action
- entry
- Agreement
- notes offering
- Counterparty
- ARYA Sciences Holdings IV (the Sponsor)
- Value
- $1,000,000
- Effective
- 2024-02-08
Exact text from the filing
On February 8, 2024, ARYA Sciences Acquisition Corp IV (the "Company") issued an unsecured convertible promissory note (the "Fourth Promissory Note") to ARYA Sciences Holdings IV (the "Sponsor"), pursuant to which the Company may borrow $1,000,000 (the "Working Capital Loan") from the Sponsor for general corporate purposes and the funding of the deposits required to be made into the Company's trust account in connection with the monthly extensions of the time period during which the Company may consummate a Business Combination
View on SEC.gov